CellFiber Opens US Subsidiary in Philadelphia to Accelerate Scalable Manufacturing of iPSC, MSC, and CAR-T Cell Therapies
New office and laboratory at CIC Philadelphia will support US biopharma companies, CDMOs, and research institutions developing cell and gene therapies (CGT) and advanced therapy medicinal products (ATMPs) in adopting CellFiber® 3D cell culture technology PHILADELPHIA and TOKYO, Oct. 9,...
Covered in this story
Call it yourself
No calls on $MSC yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Studio City International Holdings →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.